HOME >> MEDICINE >> NEWS
Cancer researchers seek to predict tumor growth

them in their 20s and 30s. "These patients are resistant to current drugs on the market," Dr. Kinsella says. "We need to find out why and how these cellular repair processes go awry."

"Because the problem being studied involves biological processes that evolve at various levels (molecular, cellular, tissue, organ), and the individual dynamical processes interact at multiple spatial and temporal scales, this provides a unique and challenging opportunity for the application of systems and control methodologies," says Kenneth A. Loparo, Ph.D., a co-principal investigator of the study and a professor in electrical engineering and computer science at the Case School of Engineering, "We are developing new modeling and analysis approaches based on a systems concept, and this work should provide new insight into the complex processes involved in the dynamics of cancer."

The ICBP initiative highlights nine integrative biology centers. These centers will provide the nucleus for the design and validation of computational and mathematical cancer models. The models will simulate complex cancer processes, and will be used to address all stages of cancer, from the basic cellular processes through tumor growth and metastasis. "The key aspect that sets the ICBP effort apart from others," said Daniel Gallahan, Ph.D., Associate Director, Division of Cancer Biology, NCI, "is the focus on building predictive cancer models, and not just analyzing data."

The ICBP centers also will serve as training and outreach programs, enabling developing technologies to be communicated to other scientists in the cancer research community. This outreach effort adds another level of integration, and also provides the means for other scientists to validate the usefulness of these models.

The new ICBP centers represent a broad spectrum of cancer research. The centers and their individual projects include Massachusetts General Hospital, Boston, "Development of Virtual
'"/>

Contact: George Stamatis
George.Stamatis@case.edu
216-368-3635
Case Western Reserve University
8-Nov-2004


Page: 1 2 3

Related medicine news :

1. Cancer in patients with hepatitis C
2. Olson family donates $1 million to Arizona Cancer Center
3. Cancer vaccines: A two-pronged attack?
4. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI
5. ESMO and Imedex announce partnership for the World Congress on Gastrointestinal Cancer
6. UT Southwestern Moncrief Cancer Center is first in Texas to treat patients with TomoTherapy
7. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research
8. Cancer patients in Europe unite with doctors
9. Fox Chase Cancer Center researchers identify novel target for detecting ovarian cancer in blood
10. Cancer burden seen even many years after diagnosis
11. Cancer cell detection technology wins Kaye Award for Hebrew University researchers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer researchers seek predict tumor growth

(Date:5/20/2013)... May 20, 2013 yurbuds®, maker of ... out, today announced the launch of its new Signature ... Series-Pete Jacobs, with more signature athletes to come. Created ... Signature Series ITE 100 is the perfect training partner ... ITE 100 features reflective, tangle-resistant Kevlar cords, premium sound ...
(Date:5/20/2013)... The judge overseeing pretrial proceedings in the federal ... female lawyers to be included in a plaintiffs’ leadership ... acknowledges the judge’s request, noting that its lawyers ... on Mirena side effects and how to file a ... of some female lawyers to the committee. This followed ...
(Date:5/20/2013)... WINSTON-SALEM, N.C. May 20, 2013 Nearly 20 ... in the U.S. are refused for transplant due to ... the kidney,s filtering units to the organ going too ... of being discarded, these organs could be "recycled" to ... Researchers at Wake Forest Baptist Medical Center and colleagues, ...
(Date:5/20/2013)... Amsterdam, NL, 20 May 2013 While Huntington,s ... community anticipates that new disease-modifying therapies in development ... success of HD research depends upon the identification ... and evaluate therapies, and these biomarkers may eventually ... Biomarkers could be especially helpful to monitor changes ...
(Date:5/20/2013)... Dorland Health, a division of ... annual Case In Point Platinum Awards, recognizing outstanding ... the system is patient- and family-centric, safe and ... creative work across the healthcare system that is ... of care through effective care coordination across the ...
Breaking Medicine News(10 mins):Health News:yurbuds Expands Best-Selling Lines with Innovative New Products 2Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2Health News:Study suggests new source of kidneys for transplant 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3Health News:Dorland Health Announces the 2013 Case In Point Platinum Awards Winners 2
(Date:5/20/2013)... , May 20, 2013 Sequent Medical, ... for the SL ("Single Layer") family of WEB ® ... release of these new models in select neurovascular centers ... and superior navigability that will enable physicians to treat ... The SL configurations are made possible by ...
(Date:5/20/2013)... ATLANTA , May 20, 2013  Atlantic ... developed and is commercializing a unique technology to ... founder and President, Anthony Soscia ... the Atlanta Business Chronicle ,s Health-Care Heroes ... Atlanta Business Chronicle to honor individuals and ...
(Date:5/20/2013)... 20, 2013 Enrollment of patients with Type ... dose-finding clinical trial of product candidate NewMet ™, ... for Type 2 diabetes. Elcelyx expects to complete enrollment ... June. Results of the trial,s primary endpoint of change ... and the read-out for long-term glucose lowering and weight ...
Breaking Medicine Technology:Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4
Cached News: